IPP Bureau
Alithea Genomics, Revvity partner to expand global access to Transcriptomics for drug discovery
By IPP Bureau - June 16, 2026
Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research
Lumos Health opens applications for second cohort of HealthTech and MedTech startups
By IPP Bureau - June 16, 2026
Healthcare speed-scaling platform offers clinical validation, regulatory support, mentorship, and investor access to startups working across preventive health, oncology, genomics, diagnostics, and digital health
India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh
By IPP Bureau - June 16, 2026
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids
By IPP Bureau - June 16, 2026
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial
By IPP Bureau - June 16, 2026
The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor
Roche wins FDA approval for first PTEN-loss companion diagnostic in prostate cancer
By IPP Bureau - June 16, 2026
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI
By IPP Bureau - June 16, 2026
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy
By IPP Bureau - June 15, 2026
Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform
Ramkrishna CARE Hospitals’s dedicated cancer institute to open in August 2026
By IPP Bureau - June 15, 2026
The new institute will strengthen oncology infrastructure in central India with advanced radiation therapy, multidisciplinary expertise, and comprehensive cancer care services
Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push
By IPP Bureau - June 15, 2026
Dr Reddy’s has partnered with MSN Laboratories Private Limited on the product, with Dr Reddy’s holding exclusive US marketing rights while MSN leads development and manufacturing
Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai
By IPP Bureau - June 15, 2026
The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments
Leprosy elimination drive intensifies as Indian govt pushes high-burden states toward zero transmission goal
By IPP Bureau - June 15, 2026
Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
Cohere Health’s Global Innovation Centre recognized as impactful at ET Edge GCC Summit
By IPP Bureau - June 15, 2026
Award highlights Hyderabad-based innovation hub’s role in advancing healthcare technology, clinical intelligence, and global operational excellence
Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO
By IPP Bureau - June 15, 2026
Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
